Fasce F, Spinelli A, Bolognesi G, Rossi M, Gemma M
Department of Ophthalmology and Visual Sciences, University Hospital San Raffaele, Milano, Italy.
Eur J Ophthalmol. 2007 Sep-Oct;17(5):709-13. doi: 10.1177/112067210701700504.
To compare the efficacy of 2.5% sodium hyaluronate (BD Multivisc) with the soft shell technique in reducing corneal endothelial cell damage during cataract phacoemulsification in patients with hard lens nucleus (3+) and cornea guttata.
Thirty patients (37 eyes) scheduled for cataract surgery at Department of Ophthalmology and Visual Sciences, University Hospital San Raffaele, Milano, Italy. Thirty-seven eyes (randomly divided into Groups A and B) with hard lens nucleus (grade 3 or higher) and cornea guttata had phacoemulsification using the soft shell technique (Group A) with Biolon (sodium hyaluronate 1%) and Viscoat (sodium hyaluronate 3%-chondroitin sulfate 4%) or with BD Multivisc alone (Group B). Patients were evaluated preoperatively and after 1, 15, 90, and 180 days, checked for best-corrected visual acuity (BCVA), intraocular pressure (IOP), central corneal thickness, and corneal endothelial density. Stop and chop phacoemulsification technique, with burst mode (Alcon Legacy 20000, Advantec), was performed.
There were no significant differences between the two groups at 3 and 6 months in BCVA, IOP, corneal thickness, or endothelial cell density. The increase of central corneal thickness (preoperative: Group A 584+/-30 microm, Group B 573+/-30 microm; postoperative at 90 days: Group A 593+/-38 microm, Group B 577+/-25 microm) was not significant. Endothelial cell loss was similar in both groups.
The results suggest that the soft shell technique (Biolon, Viscoat) and 2.5% sodium hyaluronate (BD Multivisc) are both effective in protecting the corneal endothelium in Fuchs dystrophy during phacoemulsification in patients with hard lens nucleus.
比较2.5%透明质酸钠(BD Multivisc)与软壳技术在硬核(3级)和角膜滴状变性患者白内障超声乳化术中减少角膜内皮细胞损伤的疗效。
意大利米兰圣拉斐尔大学医院眼科和视觉科学部计划进行白内障手术的30例患者(37只眼)。37只患有硬核(3级或更高)和角膜滴状变性的眼睛(随机分为A组和B组),采用软壳技术(A组)联合Biolon(1%透明质酸钠)和Viscoat(3%透明质酸钠-4%硫酸软骨素)或单独使用BD Multivisc进行超声乳化。术前及术后1、15、90和180天对患者进行评估,检查最佳矫正视力(BCVA)、眼压(IOP)、中央角膜厚度和角膜内皮密度。采用爆破模式(爱尔康Legacy 20000,Advantec)的拦截劈核超声乳化技术。
两组在3个月和6个月时的BCVA、IOP、角膜厚度或内皮细胞密度无显著差异。中央角膜厚度的增加(术前:A组584±30微米,B组573±30微米;术后90天:A组593±38微米,B组577±25微米)不显著。两组的内皮细胞损失相似。
结果表明,软壳技术(Biolon、Viscoat)和2.5%透明质酸钠(BD Multivisc)在硬核患者白内障超声乳化术中对Fuchs角膜营养不良患者的角膜内皮均有有效的保护作用。